{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:01:54Z","timestamp":1792674114910,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vaccine.2017.03.102","type":"journal-article","created":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T18:00:48Z","timestamp":1496167248000},"page":"3101-3111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Influenza viruses production: Evaluation of a novel avian cell line DuckCelt\u00ae-T17"],"prefix":"10.1016","volume":"36","author":[{"given":"Emma","family":"Petiot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Proust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Traversier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Durous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Dappozze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Gras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Guillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Balloul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rosa-Calatrava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.03.102_b0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00253-012-4238-2","article-title":"CAP, a new human suspension cell line for influenza virus production","volume":"97","author":"Genzel","year":"2013","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2017.03.102_b0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-2659.2008.00053.x","article-title":"FluBlok, a recombinant hemagglutinin influenza vaccine","volume":"2","author":"Cox","year":"2008","journal-title":"Influenza Other Respi Viruses"},{"key":"10.1016\/j.vaccine.2017.03.102_b0015","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.biologicals.2009.02.014","article-title":"FluBlok, a next generation influenza vaccine manufactured in insect cells","volume":"37","author":"Cox","year":"2009","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2017.03.102_b0020","unstructured":"Couture MM-J, Dargis M, Lavoie P-O, Vezina L-P, D\u2019Aoust M-A. Chimeric influenza virus-like particles comprising hemagglutinin. WO 2010\/148511A1; 2010."},{"key":"10.1016\/j.vaccine.2017.03.102_b0025","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.1016\/j.vaccine.2015.06.110","article-title":"Cell substrates for the production of viral vaccines","volume":"33","author":"Aubrit","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.102_b0030","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1586\/erv.09.128","article-title":"Continuous cell lines as a production system for influenza vaccines","volume":"8","author":"Genzel","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.03.102_b0035","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1016\/j.vaccine.2010.07.004","article-title":"A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor","volume":"28","author":"Lohr","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.102_b0040","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.1016\/j.vaccine.2010.08.059","article-title":"Production and antigenic properties of influenza virus from suspension MDCK-siat7e cells in a bench-scale bioreactor","volume":"28","author":"Chu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.102_b0045","first-page":"1","article-title":"Serum-free suspension culture of MDCK cells for production of influenza H1N1 Vaccines","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.03.102_b0050","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/S0264-410X(00)00508-9","article-title":"The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines","volume":"19","author":"Pau","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.102_b0055","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1016\/j.vaccine.2010.03.029","article-title":"Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing","volume":"28","author":"Le Ru","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.102_b0060","article-title":"The avian EB66\u00ae cell line, application to vaccines, and therapeutic protein production","author":"Brown","year":"2010","journal-title":"PDA J Pharm Sci Technol"},{"key":"10.1016\/j.vaccine.2017.03.102_b0065","unstructured":"Fabry L, Knott I, Vassilev VB. Process for preparing an influenza seed virus for vaccine manufacture; 2009."},{"key":"10.1016\/j.vaccine.2017.03.102_b0070","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1016\/j.vaccine.2009.05.083","article-title":"New avian suspension cell lines provide production of influenza virus and MVA in serum-free media: studies on growth, metabolism and virus propagation","volume":"27","author":"Lohr","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.102_b0075","unstructured":"Erbs P, Kapfer M, Silvestre N. Immortalized avian cell lines. WO 2009004016 A1, n.d."},{"key":"10.1016\/j.vaccine.2017.03.102_b0080","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.virol.2012.05.019","article-title":"The influenza fingerprints: NS1 and M1 proteins contribute to specific host cell ultrastructure signatures upon infection by different influenza A viruses","volume":"432","author":"Terrier","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.03.102_b0085","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1021\/jp211845t","article-title":"Modeling elastic pore sensors for quantitative single particle sizing","volume":"116","author":"Kozak","year":"2012","journal-title":"J Phys Chem C"},{"key":"10.1016\/j.vaccine.2017.03.102_b0090","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1021\/ac200195n","article-title":"Quantitative sizing of nano\/microparticles with a tunable elastomeric pore sensor","volume":"83","author":"Vogel","year":"2011","journal-title":"Anal Chem"},{"key":"10.1016\/j.vaccine.2017.03.102_b0095","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.apcatb.2013.03.037","article-title":"Photocatalysis on yeast cells: toward targets and mechanisms","volume":"140\u2013141","author":"Thabet","year":"2013","journal-title":"Appl Catal B Environ"},{"key":"10.1016\/j.vaccine.2017.03.102_b0100","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1472-6750-11-84","article-title":"Metabolic and kinetic analyses of influenza production in perfusion HEK293 cell culture","volume":"11","author":"Petiot","year":"2011","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.vaccine.2017.03.102_b0105","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.vaccine.2014.02.016","article-title":"High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells","volume":"32","author":"Genzel","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.102_b0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1472-6750-14-72","article-title":"The avian cell line AGE1.CR.pIX characterized by metabolic flux analysis","volume":"14","author":"Lohr","year":"2014","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.vaccine.2017.03.102_b0115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.virol.2007.04.006","article-title":"Generation of the influenza B viruses with improved growth phenotype by substitution of specific amino acids of hemagglutinin","volume":"365","author":"Lugovtsev","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.03.102_b0120","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1016\/j.vaccine.2009.06.024","article-title":"Use of MDCK cells for production of live attenuated influenza vaccine","volume":"27","author":"Liu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.102_b0125","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00253-010-2742-9","article-title":"MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation","volume":"88","author":"Genzel","year":"2010","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2017.03.102_b0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1472-6750-12-79","article-title":"Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells","volume":"12","author":"Lohr","year":"2012","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.vaccine.2017.03.102_b0135","article-title":"Real-time monitoring of influenza virus production kinetics in HEK293 cell cultures","author":"Petiot","year":"2012","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.vaccine.2017.03.102_b0140","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1016\/j.vaccine.2015.05.097","article-title":"Influence of HEK293 metabolism on the production of viral vectors and vaccine","volume":"33","author":"Petiot","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.102_b0145","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/bit.22364","article-title":"Cell density effect in the baculovirus-insect cells system: a quantitative analysis of energetic metabolism","volume":"104","author":"Bernal","year":"2009","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2017.03.102_b0150","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jbiotec.2005.03.009","article-title":"Effect of re-feed strategies and non-ammoniagenic medium on adenovirus production at high cell densities","volume":"119","author":"Ferreira","year":"2005","journal-title":"J Biotechnol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T05:27:43Z","timestamp":1535779663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17305029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":30,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0264410X17305029"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.102","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influenza viruses production: Evaluation of a novel avian cell line DuckCelt\u00ae-T17","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}